News

The French Ministry for Higher Education and Research extended Comac Medical’s approval as a research and development service provider

We have the pleasure to announce that the French Ministry for Higher Education and Research has granted an extension to the approval of Comac Medical’s Clinical Research Unit (CRU) as a research and development service provider. This allows companies, subject to the French General Tax Code, to take advantage of the research and development tax credit (Le Crédit d’Impôt Recherche (CIR) available in France.

French companies which have outsourced research and development to Comac Medical’s CRU will be able to benefit from the research and development tax credit (Le Crédit d’Impôt Recherche (CIR).

The open-data list of approved organizations is available at: https://lnkd.in/dwkdAcU

 

MEDICAL CENTER COMAC MEDICAL LTD – décision – Agr CIR

Share:
Comac Medical is proud to announce the appointment of Peter Windisch as its new Chief Operations Officer (COO).
For small to mid-sized biotech companies, navigating the complexities of clinical trials can be challenging. With limited resources,...
Sofia, November 15th 2024 – Comac Medical is proud to announce the launch of new sustainability initiatives aimed...